Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
We depend on the Hackaday community to help us find all the fresh hacks the Internet has to offer. Whenever you see something you think should be discussed on Hackaday we want to hear from you. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results